Back to Trades
Auffarth Gerd
DirectorCIK 0001649867
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Auffarth Gerd, Director, has filed 1 SEC report (2025), all concentrated in Outlook Therapeutics, Inc. (OTLK), totaling $360.4K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.